Eli Lilly and Company
LLY
$339.08
$8.382.53%
Weiss Ratings | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | A- | |||
Rating Factors | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Good | |||
Volatility Index | Good | |||
Beta / Standard Deviation | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.45 | |||
Price History | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -2.57% | |||
30-Day Total Return | -7.86% | |||
60-Day Total Return | -7.26% | |||
90-Day Total Return | 9.30% | |||
Year to Date Total Return | -7.10% | |||
1-Year Total Return | 41.87% | |||
2-Year Total Return | 73.06% | |||
3-Year Total Return | 148.13% | |||
5-Year Total Return | 381.49% | |||
52-Week High % Change | -11.80% | |||
52-Week Low % Change | 46.24% | |||
Price | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $384.44 | |||
52-Week Low Price | $231.87 | |||
52-Week Low Price (Date) | Feb 14, 2022 | |||
52-Week High Price (Date) | Jan 24, 2023 | |||
Valuation | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $322.19B | |||
Enterprise Value | 334.95B | |||
Price/Earnings (TTM) | 50.96 | |||
Earnings Per Share (TTM) | 6.65 | |||
Earnings Per Share Growth | 1.45% | |||
Price/Earnings To Growth | 35.39 | |||
Price/Sales (TTM) | 10.48 | |||
Price/Book (Q) | 30.31 | |||
Enterprise Value/Revenue (TTM) | 11.46 | |||
Price | $339.08 | |||
Enterprise Value/EBITDA (TTM) | 32.16 | |||
Enterprise Value/EBIT | 37.97 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 903.800M | |||
Dividend Yield | 1.16% | |||
Div. Per Share (Most Recent) | $0.98 | |||
Dividend Per Share (TTM) | $3.92 | |||
Payout Ratio (TTM) | 56.76% | |||
Dividend Per Share (Most Recent) | $0.98 | |||
Company Info | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 317 276 2000 | |||
Address | Lilly Corporate Center Indianapolis, IN 46285 | |||
Website | www.lilly.com | |||
Country | United States | |||
Year Founded | 1876 | |||
Profitability | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 30.16% | |||
Profit Margin | 20.63% | |||
Management Effectiveness | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 11.53% | |||
Return on Equity | 66.59% | |||
Income Statement | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $29.24B | |||
Total Revenue (TTM) | $29.24B | |||
Revenue Per Share | $32.35 | |||
Gross Profit (TTM) | $22.01B | |||
EBITDA (TTM) | $10.41B | |||
EBIT (TTM) | $8.82B | |||
Net Income (TTM) | $6.03B | |||
Net Income Avl. to Common (TTM) | $6.03B | |||
Total Revenue Growth (Q YOY) | 2.49% | |||
Earnings Growth (Q YOY) | 30.77% | |||
EPS Diluted (TTM) | $6.65 | |||
EPS Diluted Growth (Q YOY) | 31.97% | |||
Balance Sheet | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $2.82B | |||
Cash Per Share (Q) | $3.12 | |||
Total Current Assets (Q) | $17.64B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $10.17B | |||
Current Ratio (Q) | 1.127 | |||
Book Value Per Share (Q) | $11.19 | |||
Total Assets (Q) | $47.46B | |||
Total Current Liabilities (Q) | $15.65B | |||
Total Debt (Q) | $16.04B | |||
Total Liabilities (Q) | $37.30B | |||
Total Common Equity (Q) | $10.07B | |||
Cash Flow | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$2.78B | |||
Cash from Financing (TTM) | -$5.79B | |||
Net Change in Cash (TTM) | -$1.17B | |||
Levered Free Cash Flow (TTM) | $5.70B | |||
Cash from Operations (TTM) | $7.66B | |||